Women's Health Strategy Relaunch Puts 'Medical Misogyny' Back in the Spotlight
Health Secretary Wes Streeting's relaunch of the women's health strategy has reignited a national conversation about "medical misogyny" — the systemic dismissal and misdiagnosis of women's health concerns within the NHS — with campaigners welcoming the renewed commitment but calling for concrete action.
The strategy, relaunched on 14 April and continuing to generate significant discussion this week, aims to tackle the historical problem of women's health concerns being dismissed or misdiagnosed, promising a renewed effort to improve care, research, and outcomes for female patients across the UK.
Background
The term "medical misogyny" refers to a well-documented pattern in which women's symptoms are more likely to be attributed to psychological causes, dismissed as exaggeration, or simply not taken seriously by healthcare professionals. Conditions such as endometriosis, polycystic ovary syndrome, and autoimmune diseases disproportionately affect women and are frequently subject to lengthy diagnostic delays. Research has consistently shown that women wait longer for pain relief in emergency departments and are less likely to receive timely diagnoses for serious conditions.
Key Developments
The relaunched strategy includes commitments to improve training for healthcare professionals on women's health conditions, increase research funding for conditions that disproportionately affect women, and establish clearer pathways for the diagnosis and treatment of conditions such as endometriosis. The strategy also addresses menopause care, with commitments to improve access to hormone replacement therapy and specialist menopause clinics.
Why It Matters
The NHS serves millions of women, and systemic biases in how their health concerns are treated have real and sometimes devastating consequences. Improving women's health outcomes is not only a matter of fairness but also has significant economic implications, as untreated or poorly managed conditions lead to lost productivity and increased long-term healthcare costs.
What's Next
Campaigners are calling for the strategy to be backed by specific, measurable targets and ring-fenced funding. Parliamentary scrutiny of the strategy's implementation is expected in the coming months. For more, see The Guardian.
